Trial intelligence / Profile preview

Potassium Citrate for Nephrocalcinosis Prevention in Preterm Infants

NCT01756547Phase 3Unknown

Start
Jan 2013
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of potassium citrate in nephrocalcinosis. Status: unknown.

02

Drugs

potassium citrate
03

Conditions

nephrocalcinosis

Beyond the preview

Go deeper on NCT01756547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01756547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call